CVS Health slims debt with buyback
CVS Health Corp jumped at the opportunity to conduct a liability management exercise this week, as US corporate bond issuance began to tail off amid signs of investor caution in the run-up to the year’s end.
Issuance was lower than expected as some borrowers who had looked to pre-fund for 2021 paused.
“As we approach year end, investors are becoming more cautious, dealers are reducing balance sheet risk and there is also the rise in Covid cases,” said a dealer.
EPFR reported a $4.2bn outflow ...Already a subscriber? Login